scispace - formally typeset
I

Inge Klinkenberg

Researcher at Maastricht University

Publications -  11
Citations -  1202

Inge Klinkenberg is an academic researcher from Maastricht University. The author has contributed to research in topics: Biperiden & Muscarinic antagonist. The author has an hindex of 7, co-authored 11 publications receiving 1038 citations. Previous affiliations of Inge Klinkenberg include European Graduate School.

Papers
More filters
Journal ArticleDOI

The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies

TL;DR: It is concluded that effects on learning and memory performance which are observed after higher doses of scopolamine are mediated by primary effects on attention and sensory/stimulus discrimination, and non-specific effects on behavior (e.g., locomotor activity, anxiety).
Journal ArticleDOI

Acetylcholine and attention.

TL;DR: The role of ACh in cognition is different per brain region and between nicotinic versus muscarinic receptor subtypes, and in contrast, cholinergic signaling in the septohippocampal system is suggested to be involved in memory processes.
Journal ArticleDOI

A systematic review of social support interventions for caregivers of people with dementia: Are they doing what they promise?

TL;DR: There is insufficient evidence to conclude whether a change in social support is the underlying mediating factor for caregiver well-being, but the inclusion, validation and operationalization of caregiver social support measures deserve more attention.
Journal ArticleDOI

The use of a test battery assessing affective behavior in rats: order effects.

TL;DR: The present study indicates that the performance of rats in a test can be dependent on the order in atest battery, and caution the interpretation of treatment effects in studies in which test batteries are used.
Journal ArticleDOI

A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.

TL;DR: Muscarinic m1 antagonists should be considered an interesting alternative for SCOP as a pharmacological model for cholinergic mnemonic deficits in animals.